PATENT CLAIM ANALYSIS

Application Number: 15745938
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "187000"]

Abstract:
Organometallic compounds comprising a chloroquinoline moiety for use in the prophylaxis and treatment of malaria. The compounds can be manganese or rhenium complexes of a ligand comprising a chloroquinoline moiety.

Claim (Index 1):
A method of treatment or prophylaxis of malaria comprising administering to an individual who has been diagnosed with, is suffering from, or is at risk of developing malaria comprising administering to the individual a therapeutically effective amount of a composition comprising one of more compounds of the following formula: wherein:\n M is Mn or Re, \n L is a neutral, two-electron donor ligand, \n R 1  is H or an amine-substituted alkyl group, \n R 2  is H, (CH 2 ) n CH 3 , wherein n is 0 or any integer from 1 to 20, OMe, OEt, OPh, Ph, CHO, COMe, COPh, CH 2 OH, CO 2 H, CO 2 Me, CO 2 Et, CH 2 Ph, NH 2 , NMe 2 , NEt 2 , C 6 H 4 Me, C 6 H 4 OMe, NH 2 COMe, F, Cl, Br, or I; and \n E is a linker moiety connecting the cyclopentadienyl moiety with the chloroquinoline moiety.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 86.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15541300', '15090848', '11884547', '13300511', '13951340']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7273777921864903
- 35 USC 102 Novelty (BERT): 0.4847898441341998
- Combined Prediction Score: 0.7031189973812614
- Mean Citation Score: 155.385986
- Max Citation Score: 182.91335
- Similarity Product: 128.39235438945892

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test